Ovid Therapeutics Inc.·4

Jan 23, 4:45 PM ET

Ward Ana 4

4 · Ovid Therapeutics Inc. · Filed Jan 23, 2018

Insider Transaction Report

Form 4
Period: 2018-01-19
Ward Ana
SVP and General Counsel
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2018-01-19+20,00020,000 total
    Exercise: $9.18Exp: 2028-01-18Common Stock (20,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the Stock Option will vest and become exercisable on January 19, 2019 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued service through each such date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION